HIT Stock Analysis: Buy, Sell, or Hold?
HIT - Health In Tech, Inc. Class A Common Stock
$1.34
0.03 (2.69%)
▲
5d:
-26.65%
30d:
-3.26%
90d:
-27.84%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 13, 2026
12d
Get Alerted When HIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HIT is down 26.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HIT is down 26.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
69.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HIT is currently trading at $1.33, which is considered fair relative to its 30-day fair value range of $1.28 to $1.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.5) compared to its historical average (37.3). Remarkably, the market is currently pricing in an annual earnings decline of 44.1% over the next few years. This pessimistic expectation contrasts with the company's recent 10.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HIT is showing sideways momentum. Immediate support is located at $1.22, while resistance sits at $2.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.25 (+226.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HIT is showing sideways momentum. Immediate support is located at $1.22, while resistance sits at $2.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.25 (+226.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.28 -
$1.90
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 226.9% below Wall St target ($4.25)
- WARNING: Recommendation downgraded due to -26.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.28 -
$1.90
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$2.09
Current Trend
Sideways
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.50
Wall Street Target
$4.25
(+226.9%)
Revenue Growth (YoY)
53.1%
Earnings Growth (YoY)
10.3%
Profit Margin
3.8%
Valuation Discount vs History
-44.1% cheaper
PE vs Historical
6.5 vs 37.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-44.1%
(market-implied from PE analysis)
1-Year Target
$1.17
(-10%)
2-Year Target
$1.05
(-19%)
3-Year Target
$0.95
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→37)
$5.44
(+318%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (90x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 90.00 | Current EPS (TTM): $0.02
Bull Case
$2.28
(+29%)
Analyst growth 15.0%, PE expands to 99.0
Base Case
$2.07
(+17%)
Market implied 15.0%, PE stable at 90.0
Bear Case
$1.22
(-31%)
Severe decline -20.0%, PE contracts to 76.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.5 to 37.3
Stabilization Target:
$7.46
(+473.8%)
PE Expansion Potential:
+473.8%
Share & Embed Analysis
Last updated: March 31, 2026 12:35 PM ET
Data refreshes hourly during market hours. Next update: 1:35 PM
Data refreshes hourly during market hours. Next update: 1:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIT showing a specific setup today?
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HUBS
HubSpot Inc |
STRONG BUY
36 analysts |
$377 | 52 HOLD |
|
UBER
Uber Technologies Inc |
STRONG BUY
54 analysts |
$104 | 54 HOLD |
|
NOW
ServiceNow Inc |
STRONG BUY
47 analysts |
$189 | 47 HOLD |
|
DDOG
Datadog Inc |
STRONG BUY
46 analysts |
$182 | 54 HOLD |
|
CRM
Salesforce.com Inc |
STRONG BUY
55 analysts |
$274 | 56 HOLD |
